Antibody
APP (8E5)
Quick Links
Clonality: monoclonal
Host: Mouse
Source: anti-APP 8E5
(P. Seubert and D. Schenk,
Elan Pharmaceuticals, South San Francisco, CA)
References:
Britschgi, 2009
Rose, 2009
Maier, 2008
Roberson, 2007
Esler, 2002,
Van Uden, 2002
Choi, 2006
Reactivity:
Reacts in: Human
reference: McConlogue L, Castellano F, deWit C, Schenk D, and Maltese W.A. J. Biol. Chem. 271, 1343-1348, 1996
Immunogen/Epitope
immunogen = residues 444-592 of APP
Specificity
residues 444-592 of APP in the AβPP695 ectodomain and AβPPs
References
Paper Citations
- Britschgi M, Olin CE, Johns HT, Takeda-Uchimura Y, Lemieux MC, Rufibach K, Rajadas J, Zhang H, Tomooka B, Robinson WH, Clark CM, Fagan AM, Galasko DR, Holtzman DM, Jutel M, Kaye JA, Lemere CA, Leszek J, Li G, Peskind ER, Quinn JF, Yesavage JA, Ghiso JA, Wyss-Coray T. Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease. Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12145-50. PubMed.
- Rose JB, Crews L, Rockenstein E, Adame A, Mante M, Hersh LB, Gage FH, Spencer B, Potkar R, Marr RA, Masliah E. Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease. J Neurosci. 2009 Jan 28;29(4):1115-25. PubMed.
- Maier M, Peng Y, Jiang L, Seabrook TJ, Carroll MC, Lemere CA. Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice. J Neurosci. 2008 Jun 18;28(25):6333-41. PubMed.
- Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science. 2007 May 4;316(5825):750-4. PubMed.
- Esler WP, Kimberly WT, Ostaszewski BL, Ye W, Diehl TS, Selkoe DJ, Wolfe MS. Activity-dependent isolation of the presenilin- gamma -secretase complex reveals nicastrin and a gamma substrate. Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2720-5. PubMed.
- Van Uden E, Mallory M, Veinbergs I, Alford M, Rockenstein E, Masliah E. Increased extracellular amyloid deposition and neurodegeneration in human amyloid precursor protein transgenic mice deficient in receptor-associated protein. J Neurosci. 2002 Nov 1;22(21):9298-304. PubMed.
- Choi DS, Wang D, Yu GQ, Zhu G, Kharazia VN, Paredes JP, Chang WS, Deitchman JK, Mucke L, Messing RO. PKCepsilon increases endothelin converting enzyme activity and reduces amyloid plaque pathology in transgenic mice. Proc Natl Acad Sci U S A. 2006 May 23;103(21):8215-20. Epub 2006 May 12 PubMed.
Further Reading
News
- Going Wild About the Latest TDP-43 Mouse Models
- Research Brief: There’s a Fly in My TDP-43 Research
- Meet the First Published TDP-43 Mouse
- London, Ontario: TDP-43 Across the Animal Kingdom at ALS Meeting
- TDP-43 Roundup: New Models, New Genes
- Heady Times for Researchers Studying TDP-43
- Toxic TDP-43 Truncates Point to Gain-of-Function Role in Disease
- TDP-43: Modified and On the Move
Comments / Questions
No Available Comments
Make a comment or submit a question
To make a comment you must login or register.